Pramodini Medicare Ltd. IPO Details
Pramodini Medicare was incorporated on September 12, 2000. The company is a technology-enabled diagnostic service provider offering radiology, clinical laboratory, nuclear medicine, and 24×7 teleradiology services to public and private hospitals, PSUs, and medical colleges across India. Its comprehensive diagnostic solutions support disease detection, diagnosis, prevention, and monitoring through routine and specialized testing
| Bidding Dates |
|---|
| 12 Aug 2026 - 14 Aug 2026 |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹2,64,000 | 2 | 2 | 1200 | 5.9 M | ₹110 - ₹118 | 62.64 % | ₹643.6 M - ₹690.4 M | RHP DOC |
Pramodini Medicare issue details
Pramodini Medicare has 5.9 M shares on offer
Pramodini Medicare IPO offer price is in the range ₹110 - ₹118
Pramodini Medicare IPO minimum Investment is ₹264000
Pramodini Medicare IPO issue size is ₹ 643.6 M - ₹ 690.4 M
Pramodini Medicare has a minimum lot size of 1200 Shares per application
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
Pramodini Medicare IMPORTANT IPO DATES
| Issue Open Date | 12 Aug 2026 |
| Issue close Date | 14 Aug 2026 |
| Allotment Date | 17 Aug 2026 |
| Refund Date | 18 Aug 2026 |
| Demat Account Credit Date | 18 Aug 2026 |
| Listing Date | 19 Aug 2026 |
| Listing on Exchange(s) | NSE |
Pramodini Medicare IPO subscription opens on 12 Aug 2026, and closes on 14 Aug 2026
IPO allotment for Pramodini Medicare is expected to be finalized on Monday, 17 Aug 2026
IPO listing for Pramodini Medicare will be on NSE on Wednesday, 19 Aug 2026
Pramodini Medicare NUMBER OF SHARES ON OFFER
Pramodini Medicare FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY26 | 62.3 | 17.4 | 25.4 | -4.4 | 49.6% |
| FY25 | 38.2 | 11.1 | 22.1 | 12.1 | 54.8% |
| FY24 | 35.2 | 7.1 | 9.9 | 9.5 | 44.1% |
Pramodini Medicare Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pramodini Medicare Ltd. | 118 | 260.1 | 15 | 0.3 | 4.1 | 32.7 | 18.6 | 63.4 | 64.4 | 17.4 | 57.6 | 7.9 | 57.6 |
| Dr. Lal Pathlabs Ltd. | 1931.6 | 32421.7 | 59.8 | 10.7 | 11.2 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 32.3 | 5.6 |
| Inventurus Knowledge Solutions Ltd. | 1737.7 | 29814.3 | 39 | 1 | 8.9 | 25.8 | 16.9 | 3211 | 18.8 | 721.6 | 48.4 | 44.5 | 40.9 |
| Vijaya Diagnostic Centre Ltd. | 1351.1 | 13916 | 74.2 | 3 | 16.2 | 18.1 | 11.5 | 835 | 19.3 | 173 | 20.9 | 18.2 | 24.9 |
| Indegene Ltd. | 554.4 | 13357.5 | 33.3 | -4.2 | 3.5 | 12.8 | 8.7 | 3582.5 | 21.6 | 401.1 | -1.4 | 16.6 | -7.9 |
| Metropolis Healthcare Ltd. | 563.2 | 11680.1 | 57.9 | 1.8 | 6.8 | 12.6 | 8.9 | 1671.4 | 24.1 | 190 | 31.1 | 9.7 | 32.6 |
Pramodini Medicare INFORMATION ON IPO ISSUE
About Pramodini Medicare
Pramodini Medicare was incorporated on September 12, 2000. The company is a technology-enabled diagnostic service provider offering radiology, clinical laboratory, nuclear medicine, and 24×7 teleradiology services to public and private hospitals, PSUs, and medical colleges across India. Its comprehensive diagnostic solutions support disease detection, diagnosis, prevention, and monitoring through routine and specialized testing
Object of the Issue
- Funding of capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres
- General corporate purposes & unidentified inorganic acquisition
Pramodini Medicare - PROMOTERS
| Name |
|---|
| Chalasani Kuldeep Kumar |
| Chalasani Kavitha |
| Chalasani Durga Aashritha |
| Chalasani Lalithakumari |
| Sri Ram Medicare Private Limited |
Pramodini Medicare - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Chalasani Kuldeep Kumar | Chairman & Managing Director |
| Chalasani Kavitha | Non Executive Director |
| Chalasani Durga Aashritha | Non Executive Director |
| A Ajay Kumar | Non-Executive Independent Director |
| Eshwar Chandra Nandury | Non-Executive Independent Director |
| Manas Dash | Non-Executive Independent Director |
Pramodini Medicare Book Running Lead Manager
Smart Horizon Capital Advisors Private Limited
director@shcapl.com
Pramodini Medicare Registrar to the Offer
Purva Sharegistry (India) Private Limited
newissue@purvashare.com
Pramodini Medicare Strengths
Diversified models
The company provides technology-enabled diagnostic services through public-private partnerships, private hospital collaborations, PSU partnerships, and standalone centres across Tier I, II, and III cities in India. Its extensive network and hospital-based service model enable quality diagnostic services and support consistent business growth
Technical capabilities
The company leverages advanced diagnostic technology and modern equipment to deliver accurate, reliable, and efficient diagnostic services with faster turnaround times. Its strong vendor relationships, skilled technical team, and advanced imaging infrastructure support scalable operations and high-quality patient care
Diversified client base
The company serves a diversified customer base across B2B, B2C, and B2G segments, strengthening its market presence and credibility. Its patient-centric approach, standardized diagnostic centres, and focus on quality services enhance patient satisfaction, retention, and brand recognition
Pramodini Medicare Risks
Specimen handling & transport risk
The company relies on proper specimen collection, packaging, transportation, and timely delivery to ensure accurate diagnostic results. Any errors, delays, damage, or contamination during these processes could affect test accuracy, increase costs, harm its reputation, and adversely impact business performance
Depend on radiology services
The company's significant reliance on radiology services exposes it to risks associated with high capital investment, equipment maintenance, and stringent regulatory requirements. Any disruption in radiology operations or non-compliance with applicable regulations could adversely affect its business, financial performance, and growth prospects
Technology innovation risk
The company's growth depends on continuously introducing new diagnostic tests, technologies, and equipment to meet evolving healthcare needs and remain competitive. Any failure to adopt new technologies, upgrade equipment, or train employees effectively could reduce testing volumes, revenue, and overall business performance
IPO FAQs
This IPO consists of an offer for sale of up to Rs 5.9 crore, of 500,400 shares. It also consists of a fresh issue of Rs 63.1 crore.
The promoters of the company are Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumari and Sri Ram Medicare Private Limited.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 110.0 - 118.0.
The IPO application opens on Aug 12, 2026 and closes on Aug 14, 2026.
The minimum lot size for the IPO is 2400. The maximum lot size for the IPO is 2400.
For all category investors, the minimum application amount for this IPO is Rs. 264,000.0, the maximum value for this IPO is Rs 283,200.0.
This IPO will be allotted on Aug 17, 2026.
The refund will be credited to your account on Aug 18, 2026.
The allotted shares will be credited to your demat on Aug 18, 2026.
Pramodini Medicare Ltd.’s shares will list on the stock exchanges on Aug 19, 2026.